L791943 is a selective antagonist for the neurokinin-1 (NK1) receptor, which plays a key role in mediating the effects of substance P, a neurotransmitter involved in pain signaling and inflammation. Due to its ability to block this pathway, L791943 has been primarily used in research settings to study the physiological and pathological roles of substance P in conditions such as chronic pain, neuroinflammation, and mood disorders like anxiety and depression. It has also been investigated for its potential in understanding emesis (vomiting) control, particularly in response to chemotherapy, as the NK1 receptor is heavily involved in nausea pathways. Its application remains largely experimental, serving as a tool compound in preclinical studies to validate the therapeutic potential of NK1 receptor inhibition.